Euphrates Vascular
Sean Morris is an accomplished executive in the medical device industry, currently serving as President and CEO of Amplifi Vascular, Inc. and Artio Medical, Inc., both since December 2022. Additionally, Sean holds the position of Chief Executive Officer and Board Member at Euphrates Vascular, contributing to the development of transformative devices for vascular occlusions. Previous experience includes roles as President and CEO of Pulse Therapeutics, Inc., and Founder and CEO of Veniti, which was acquired by Boston Scientific in 2018. Sean served on the Board of Directors for Vetex Medical and held various managerial positions at AngioDynamics and Aerial Communications. Sean possesses a Bachelor of Science in Biochemistry and Nutrition from Missouri State University.
This person is not in any teams
Euphrates Vascular
Euphrates Vascular develops medical devices that treat vascular occlusions related to vascular disease. Euphrates Vascular's Magnetically-Enhanced Diffusion system uses patented magnet-based technology to transport iron-oxide MED MicroBeads and clot-busting drugs at a much faster rate than otherwise possible, enabling doctors to improve carefor stroke and other diseases.Euphrates Vascular was created through the merger of Pulse Therapeutics and ICHOR Vascular.